The Chronic Lymphocytic Leukemia Summit will familiarize family medicine/primary care physicians, oncologists, internal medicine physicians, hematologists, and other clinicians with chronic lymphotic leukemia (CLL). At the end of this course, participants will be able to consider factors such as disease characteristics, age, performance status, and comorbidities in tailoring treatment regiments specifically to patients. Participants will also be able to select strategies for treatment for patients with CLL/SLL based on prognostic factors as well as patient-specific clinical criteria. Finally, this course will enable participants to analyze emerging agents for their efficacy and for strategies for assimilating those agents into clinical practice.